These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 16829121)

  • 1. Genetic and epigenetic biomarkers in cancer diagnosis and identifying high risk populations.
    Verma M; Manne U
    Crit Rev Oncol Hematol; 2006 Oct; 60(1):9-18. PubMed ID: 16829121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating cancer survival and clinical outcome based on genetic tumor progression scores.
    Rahnenführer J; Beerenwinkel N; Schulz WA; Hartmann C; von Deimling A; Wullich B; Lengauer T
    Bioinformatics; 2005 May; 21(10):2438-46. PubMed ID: 15705654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer epigenetics: the role of environmental factors and the search for molecular biomarkers.
    Ahmed FE
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(2):101-54. PubMed ID: 17558783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods in cancer epigenetics and epidemiology.
    Kumar D; Verma M
    Methods Mol Biol; 2009; 471():273-88. PubMed ID: 19109785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple genetic and epigenetic biomarkers for lung cancer detection in cytologically negative sputum and a nested case-control study for risk assessment.
    Hsu HS; Chen TP; Wen CK; Hung CH; Chen CY; Chen JT; Wang YC
    J Pathol; 2007 Dec; 213(4):412-9. PubMed ID: 17973238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic biomarkers in cancer epidemiology.
    Verma M
    Methods Mol Biol; 2012; 863():467-80. PubMed ID: 22359311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of DNA methylation for cancer detection: promises and challenges.
    Zhu J; Yao X
    Int J Biochem Cell Biol; 2009 Jan; 41(1):147-54. PubMed ID: 18834953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma.
    Hsu HS; Chen TP; Hung CH; Wen CK; Lin RK; Lee HC; Wang YC
    Cancer; 2007 Nov; 110(9):2019-26. PubMed ID: 17876837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic biomarkers in urothelial bladder cancer.
    Kim WJ; Kim YJ
    Expert Rev Mol Diagn; 2009 Apr; 9(3):259-69. PubMed ID: 19379084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global epigenetic screening technologies: a novel tool to address cancer health disparities in high-risk population groups.
    Guerrero-Preston R
    P R Health Sci J; 2008 Dec; 27(4):350-6. PubMed ID: 19069364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic alterations as cancer diagnostic, prognostic, and predictive biomarkers.
    Deng D; Liu Z; Du Y
    Adv Genet; 2010; 71():125-76. PubMed ID: 20933128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic biomarkers for human cancer: the time is now.
    Mulero-Navarro S; Esteller M
    Crit Rev Oncol Hematol; 2008 Oct; 68(1):1-11. PubMed ID: 18430583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring of human populations for early markers of cadmium toxicity: a review.
    Fowler BA
    Toxicol Appl Pharmacol; 2009 Aug; 238(3):294-300. PubMed ID: 19433102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of epigenetic events in chemical carcinogenesis--a justification for incorporating epigenetic evaluations in cancer risk assessment.
    Koturbash I; Beland FA; Pogribny IP
    Toxicol Mech Methods; 2011 May; 21(4):289-97. PubMed ID: 21495867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid chromatography mass spectrometry for quantifying plasma lysophospholipids: potential biomarkers for cancer diagnosis.
    Murph M; Tanaka T; Pang J; Felix E; Liu S; Trost R; Godwin AK; Newman R; Mills G
    Methods Enzymol; 2007; 433():1-25. PubMed ID: 17954226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asia-Pacific consensus guidelines on gastric cancer prevention.
    Fock KM; Talley N; Moayyedi P; Hunt R; Azuma T; Sugano K; Xiao SD; Lam SK; Goh KL; Chiba T; Uemura N; Kim JG; Kim N; Ang TL; Mahachai V; Mitchell H; Rani AA; Liou JM; Vilaichone RK; Sollano J;
    J Gastroenterol Hepatol; 2008 Mar; 23(3):351-65. PubMed ID: 18318820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of biological markers as predictive early-outcome measures in epidemiological research.
    McMichael AJ; Hall AJ
    IARC Sci Publ; 1997; (142):281-9. PubMed ID: 9354927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical proteomics in breast cancer: a review.
    Gast MC; Schellens JH; Beijnen JH
    Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The footprints of cancer development: Cancer biomarkers.
    Ullah MF; Aatif M
    Cancer Treat Rev; 2009 May; 35(3):193-200. PubMed ID: 19062197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges for biomarkers in cancer detection.
    Wagner PD; Verma M; Srivastava S
    Ann N Y Acad Sci; 2004 Jun; 1022():9-16. PubMed ID: 15251933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.